Congress Banned It. Europe Rejected It. CMS Is Still Giving CBD to Seniors

Audio By Carbonatix

Medicare's Hemp Program Continues Despite Federal Restrictions Taking Effect in Less Than Six Months

Court Declines to Address Safety, Legality, or Congressional Intent, Allowing CMS Hemp Program to Continue While Seniors Remain the Test Population

Duane Boise, CEO of MMJ International Holdings:

"The Court never ruled that CMS acted lawfully. The Court never ruled these products are safe. The Court never ruled Congress intended Medicare to become a distribution channel for non-FDA-approved cannabinoid products. The Court simply concluded that no one had been harmed enough yet to challenge the program. Waiting for harm before allowing judicial review is a dangerous standard when America's seniors are the ones being exposed."

As Federal Restrictions Approach and Safety Questions Mount, Medicare Beneficiaries Remain the Test Case

View the original press release on ACCESS Newswire